Qi S Y, Wang D M, Yu H B, Ding C, Tian F L, Ru L S, Li J, Zhang B, Han Y L
*Department of Cardiology, Bethune International Peace Hospital, Shijiazhuang 050082, China.
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Nov 24;44(11):951-955. doi: 10.3760/cma.j.issn.0253-3758.2016.11.010.
To analyze long-term mortality and patients characteristics of cardiac resynchronization therapy (CRT) for patients with chronic heart failure. In-patients with chronic heart failure who received CRT in the three medical centers(Bethune International Peace Hospital, General Hospital of Shenyang Military Command of Chinese People's Liberation Army, and 251 Hospital of People's Liberation Army)from March 2001 to June 2013 were included.Mortality and related causes, echocardiographic parameters were analyzed. A total of 200 patients were treated with CRT therapy (154 males, mean age (60.57±11.75) years), 59 cases suffered from ischemic cardiomyopathy (ICM), patients were followed up from 0.5 to 12 years.The all-cause mortality rate was 25.50% (51/200), 20 out of 59 (33.90%) ICM patients died, as compared with 31 deaths out of 141 (21.98%) in non-ischemic cardiomyopath (NICM) patients.Thirty-six patients died due to cardiac death (70.59%), in which sudden death occurred in 21 patients (41.18%). Non-cardiac death occurred in 13 patients (25.49%), two patients died due to unknown reasons (3.92%). Incidence of cardiac death was significantly higher than non-cardiac death (<0.01). The main cause for cardiac death was NICM (28/36, 77.78%), while the main cause of non-cardiac death was ICM (11/13, 84.62%, <0.01). Patients died due to cardiac death were younger (<0.01) and had larger left atrial end-diastolic diameter (LAEDD) and left ventricular end-diastolic diameter (LVEDD) (<0.01), lower left ventricular ejection fraction (LVEF)(<0.05), higher pulmonary artery pressure(<0.05) compared to patients with non-cardiac death.One hundred and fifty-two cases received CRT-P and 48 cases received CRT-D, there were no significant differences in gender, the course of heart failure, serum creatinine levels, pre-operative and post-operative QRS duration and so on between the CRT-P and CRT-D groups(all >0.05). Eleven out of the 48 cases with CRT-D died during the following-up (21.57%) , while 40 out of 152 cases with CRT-P died (78.43%) during the following-up(χ=3.13, <0.01). The proportional mortality rate in cause of death in patients with CRT-D was non-cardiac while in those with CRT-P was cardiac (χ=2.66, <0.01), sudden death rate was also significantly higher in CRT-P group than in CRT-D group (χ=2.16, <0.01). By using single- and multiple-factor Cox regression analysis, age, disease course, pre-operation QRS duration and NYHA classification were predictors of cardiac death(all <0.05). The all-cause mortality of CRT is 25.50% in this patient cohort, mortality rate was higher in ICM patients than in NICM patients.Sudden cardiac death rate was the highest mortality reason.The mortality rate of patients with CRT-P was significantly higher than in patients with CRT-D.In comparison with patients of non-cardiac death, patients of cardiac death had larger left atrium and left ventricle and worse heart function before CRT implantation.
分析慢性心力衰竭患者心脏再同步化治疗(CRT)的长期死亡率及患者特征。纳入2001年3月至2013年6月期间在三个医疗中心(白求恩国际和平医院、中国人民解放军沈阳军区总医院和解放军第251医院)接受CRT治疗的慢性心力衰竭住院患者。分析死亡率及相关病因、超声心动图参数。共有200例患者接受了CRT治疗(男性154例,平均年龄(60.57±11.75)岁),59例患有缺血性心肌病(ICM),对患者进行了0.5至12年的随访。全因死亡率为25.50%(51/200),59例ICM患者中有20例死亡(33.90%),而非缺血性心肌病(NICM)患者中141例有31例死亡(21.98%)。36例患者死于心源性死亡(70.59%),其中21例发生猝死(41.18%)。非心源性死亡13例(25.49%),2例死因不明(3.92%)。心源性死亡发生率显著高于非心源性死亡(<0.01)。心源性死亡的主要原因是NICM(28/36,77.78%),而非心源性死亡的主要原因是ICM(11/13,84.62%,<0.01)。死于心源性死亡的患者年龄更小(<0.01),左心房舒张末期内径(LAEDD)和左心室舒张末期内径(LVEDD)更大(<0.01),左心室射血分数(LVEF)更低(<0.05),肺动脉压更高(<0.05),与非心源性死亡患者相比。152例接受CRT-P,48例接受CRT-D,CRT-P组和CRT-D组在性别、心力衰竭病程、血清肌酐水平、术前和术后QRS时限等方面无显著差异(均>0.05)。48例CRT-D患者中有11例在随访期间死亡(21.57%),而152例CRT-P患者中有40例在随访期间死亡(78.43%)(χ=3.13,<0.01)。CRT-D患者死因的比例死亡率为非心源性,而CRT-P患者为心源性(χ=2.66,<0.01),CRT-P组的猝死率也显著高于CRT-D组(χ=2.16,<0.01)。通过单因素和多因素Cox回归分析,年龄、病程、术前QRS时限和纽约心脏协会(NYHA)分级是心源性死亡的预测因素(均<0.05)。该患者队列中CRT的全因死亡率为25.50%,ICM患者的死亡率高于NICM患者。心源性猝死率是最高的死亡原因。CRT-P患者的死亡率显著高于CRT-D患者。与非心源性死亡患者相比,心源性死亡患者在CRT植入前左心房和左心室更大,心功能更差。